 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C14H21N |
| Molar mass | 203.329 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Eticyclidine (PCE, CI-400) is a dissociative anesthetic drug with hallucinogenic effects. It is similar in effects to phencyclidine but is slightly more potent. PCE was developed by Parke-Davis in the 1970s and evaluated for anesthetic potential under the code name CI-400,[2] but research into PCE was not continued after the development of ketamine, a similar drug with more favourable properties.[3] PCE is slightly more potent than PCP and has similar effects,[medical citation needed] but its unpleasant taste and tendency to cause nausea made it less accepted by users.[citation needed] Due to its similarity in effects to PCP, PCE was placed into the Schedule 1 list of illegal drugs in the 1970s, although it was only briefly abused in the 1970s and 1980s and is now little known.
|
| |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhalational |
| ||||||||||||||
| Injection |
| ||||||||||||||
| |||||||||||||||
|
| |||||||
|---|---|---|---|---|---|---|---|
| D1-like |
| ||||||
| D2-like |
| ||||||
| |||||||
|
| |
|---|---|
| AMPARTooltip α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor |
|
| KARTooltip Kainate receptor |
|
| NMDARTooltip N-Methyl-D-aspartate receptor |
|
| |
 | This hallucinogen-related article is a stub. You can help Wikipedia by expanding it. |
